Explicyte Immuno-Oncology - Cancer Immunotherapy CRO Services
Cancer Immunotherapy CRO Services
Discovery
Custom biospecimen sourcing
Target identification
Target expression profiling
Preclinical
Tumor killing
Tumor sensitization
Activation & immune checkpoint inhibition
Antibody-dependent cell cytotoxicity (ADCC)
Tumor antigen-specific killing
Bispecific T cell engager (BiTE) killing
Antibody-Drug Conjugate (ADC) killing
Immuno-modulation
Immune cell activation
Immune cell migration
Mixed lymphocyte reaction (MLR)
Macrophage assays
TLS-GC reaction
Cytokine release syndrome
Featured
Xenium for cells
Trials
Biomarker analysis
TLS detection & evaluation
Platforms
Spatial Biology
Xenium: Single-cell spatial transcriptomics
GeoMx: Digital spatial profiling
Visium HD: Whole-Transcriptome Spatial Biology
IHC/IF: Digital pathology
Multi-Omics
Single-cell RNA Seq
Proteomics
Flow cytometry
Bioinformatics
10x Genomics Datasets
Bulk RNA-seq & GeoMx DSP Datasets
mIF & IHC Image Analysis
About
About Explicyte
Science
Commitments
News
Careers
Contact us
Toggle menu
Contact us
CRO Services
Explicyte Immuno-Oncology
>
CRO Services
View Details
Bioinformatics Services for Transcriptomic & Digital Pathology Data Analysis
View Details
Bulk RNA-seq & GeoMx DSP Dataset Analysis services
View Details
10x Genomics Data Analysis Services (Chromium X, Visium HD & Xenium)
View Details
Multi-omics platforms for bulk tissue & peripheral samples
View Details
Biomarker analysis to support oncology clinical trials
View Details
Oncology Target Identification Services Using FFPE Transcriptomics
View Details
Oncology Target Discovery Services
View Details
Oncology Target Expression Profiling in FFPE Tissues
View Details
Xenium for cells
View Details
Protected: Multispecific drug candidates characterization – Preclinical CRO services
View Details
Antibody Drug Conjugate (ADC) tumor killing
View Details
Bispecific T cell engager (BiTE) tumor killing
1
2
3
…
5
Next page
WordPress Lightbox
